Results 241 to 250 of about 1,478,450 (299)

Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cells. [PDF]

Transfusion
Karim C, Panigrahi A, Pearl RG, Sodha NR, Beaver TM, Pelletier JPR, Nuttall GA, Reece TB, Erickson A, Hedrick T, Liu K, Bentow S, Corash L, Mufti N, Varrone J, Benjamin RJ.   +15 more
europepmc   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Investigating SARS-CoV-2 Neutralising Antibody Response in Sheep. [PDF]

Microorganisms
Samojlović M, Mesquita JR, Santos-Silva S, Neptin M, Esbjörnsson J.   +4 more
europepmc   +1 more source

Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen, Jing Zhang, Xinyue Zhou, Xiaoxiao Yu, Haodong Shang, Shufan Chen, Lulu Zhen, Jinru Wu, Guanlian Hu, Xiaoyan Zhu, Zhan Sun, Yiren Wang, Jiahui Wang, Jie Lv, Xue Zhao, Yingna Zhang, Wei Guo, Ying Peng, Feng Gao   +18 more
wiley   +1 more source

Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening. [PDF]

Front Immunol
Ewaisha R, Ruffin MT, Williams S, Chung Y, DeGraffinreid CR, Paskett ED, Reiter PL, Qiu J, Brenner DE, Anderson KS.   +9 more
europepmc   +1 more source

Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong, Shasha Yu, Jing Zhang, Yu Zu, Yujing Zhang, Jing Lv, Xuyang Cao, Xuedan Feng   +7 more
wiley   +1 more source

Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants. [PDF]

MedComm (2020)
Zhang G, Wang Q, Ji K, Wang Y, Xu W, Zhou J, Liu Z, Xiu R, Xing L, Zhou J, Shi Y, Lu X, Wang X, Ying B, Lu L, Jiang S.   +15 more
europepmc   +1 more source

Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons.

JAMA
Karaba AH, Hage C, Sengsouk I, Balasubramanian P, Segev DL, Tobian AAAR, Werbel WA.   +6 more
europepmc   +1 more source

Persistence of SARS-CoV-2 Antibody Response across Diverse Clinical Settings in Oman: Insights from a Prospective ELISA-based Study. [PDF]

IJID Reg
Al Balushi A, Abdul Hameed Z, Al Bahri H, Al Maskari Z, Al Balushi A, Al Balushi I, Jose S, Al Wahaibi A, Al-Jardani A, Al-Mahruqi S, Nasr MH, Adams E, Fletcher TE, Nasr I.   +13 more
europepmc   +1 more source